Ami Fadia
Stock Analyst at Needham
(3.75)
# 669
Out of 4,905 analysts
427
Total ratings
47.61%
Success rate
8.22%
Average return
Main Sectors:
Stocks Rated by Ami Fadia
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $30 | $22.56 | +32.98% | 10 | Jun 26, 2025 | |
RVMD Revolution Medicines | Reiterates: Buy | $57 | $38.29 | +48.86% | 24 | Jun 24, 2025 | |
IMRX Immuneering | Reiterates: Buy | $9 | $4.13 | +117.92% | 17 | Jun 18, 2025 | |
COGT Cogent Biosciences | Reiterates: Hold | n/a | $12.49 | - | 23 | Jun 17, 2025 | |
SAGE Sage Therapeutics | Reiterates: Hold | n/a | $9.12 | - | 22 | Jun 16, 2025 | |
PRAX Praxis Precision Medicines | Reiterates: Buy | $80 | $53.85 | +48.56% | 12 | Jun 12, 2025 | |
BIIB Biogen | Reiterates: Hold | n/a | $124.99 | - | 41 | Jun 12, 2025 | |
JAZZ Jazz Pharmaceuticals | Reiterates: Buy | $202 | $112.87 | +78.97% | 32 | Jun 11, 2025 | |
AXSM Axsome Therapeutics | Maintains: Buy | $153 → $150 | $111.70 | +34.29% | 15 | Jun 9, 2025 | |
BPMC Blueprint Medicines | Downgrades: Hold | $130 | $129.46 | +0.42% | 31 | Jun 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $15.69 | +123.07% | 1 | May 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $29.22 | +54.00% | 1 | May 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $75 → $88 | $63.26 | +39.11% | 29 | May 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.85 | +170.27% | 9 | May 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $10.83 | +75.44% | 36 | May 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $27 | $6.40 | +321.88% | 20 | May 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $49 | $35.20 | +39.20% | 37 | May 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $139 | $132.02 | +5.29% | 14 | May 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $29 | $8.56 | +238.79% | 20 | May 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $240 → $320 | $15.83 | +1,921.48% | 2 | Feb 1, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $63 → $75 | $21.59 | +247.46% | 7 | Jan 21, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $15 → $23 | $0.92 | +2,354.72% | 4 | Oct 1, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $63 | $26.96 | +133.68% | 5 | Sep 17, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $12 → $5 | $4.94 | +1.21% | 2 | Jan 30, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $16.06 | - | 9 | Oct 1, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $22 | $1.93 | +1,039.90% | 4 | Jan 3, 2018 |
ACADIA Pharmaceuticals
Jun 26, 2025
Reiterates: Buy
Price Target: $30
Current: $22.56
Upside: +32.98%
Revolution Medicines
Jun 24, 2025
Reiterates: Buy
Price Target: $57
Current: $38.29
Upside: +48.86%
Immuneering
Jun 18, 2025
Reiterates: Buy
Price Target: $9
Current: $4.13
Upside: +117.92%
Cogent Biosciences
Jun 17, 2025
Reiterates: Hold
Price Target: n/a
Current: $12.49
Upside: -
Sage Therapeutics
Jun 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $9.12
Upside: -
Praxis Precision Medicines
Jun 12, 2025
Reiterates: Buy
Price Target: $80
Current: $53.85
Upside: +48.56%
Biogen
Jun 12, 2025
Reiterates: Hold
Price Target: n/a
Current: $124.99
Upside: -
Jazz Pharmaceuticals
Jun 11, 2025
Reiterates: Buy
Price Target: $202
Current: $112.87
Upside: +78.97%
Axsome Therapeutics
Jun 9, 2025
Maintains: Buy
Price Target: $153 → $150
Current: $111.70
Upside: +34.29%
Blueprint Medicines
Jun 2, 2025
Downgrades: Hold
Price Target: $130
Current: $129.46
Upside: +0.42%
May 28, 2025
Initiates: Buy
Price Target: $35
Current: $15.69
Upside: +123.07%
May 28, 2025
Initiates: Buy
Price Target: $45
Current: $29.22
Upside: +54.00%
May 23, 2025
Maintains: Buy
Price Target: $75 → $88
Current: $63.26
Upside: +39.11%
May 13, 2025
Reiterates: Buy
Price Target: $5
Current: $1.85
Upside: +170.27%
May 8, 2025
Reiterates: Buy
Price Target: $19
Current: $10.83
Upside: +75.44%
May 7, 2025
Maintains: Buy
Price Target: $30 → $27
Current: $6.40
Upside: +321.88%
May 7, 2025
Reiterates: Buy
Price Target: $49
Current: $35.20
Upside: +39.20%
May 6, 2025
Maintains: Buy
Price Target: $138 → $139
Current: $132.02
Upside: +5.29%
May 2, 2025
Reiterates: Buy
Price Target: $29
Current: $8.56
Upside: +238.79%
Feb 1, 2021
Maintains: Outperform
Price Target: $240 → $320
Current: $15.83
Upside: +1,921.48%
Jan 21, 2021
Downgrades: Market Perform
Price Target: $63 → $75
Current: $21.59
Upside: +247.46%
Oct 1, 2020
Maintains: Market Perform
Price Target: $15 → $23
Current: $0.92
Upside: +2,354.72%
Sep 17, 2020
Maintains: Outperform
Price Target: $64 → $63
Current: $26.96
Upside: +133.68%
Jan 30, 2019
Downgrades: Market Perform
Price Target: $12 → $5
Current: $4.94
Upside: +1.21%
Oct 1, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $16.06
Upside: -
Jan 3, 2018
Initiates: Outperform
Price Target: $22
Current: $1.93
Upside: +1,039.90%